Clinical studies recruiting near Virginia Beach

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · National Cancer Institute (NCI) · NCT05099003 A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Phase 3 · BioNTech SE · NCT07365995 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · PedAL BCU, LLC · NCT05183035 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05691478 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Pfizer · NCT07421700 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Eli Lilly and Company · NCT07415044 Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · National Cancer Institute (NCI) · NCT06860594 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Gershon Pain Specialists, Merz Investigational Site #0010519 · Merz Therapeutics GmbH · NCT07018700 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Children's Oncology Group · NCT04322318 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · NRG Oncology · NCT06532279 CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
NA · VA Office of Research and Development · NCT05996328 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Peninsula Cancer Institute-Cancer Specialists of Tidewater · NRG Oncology · NCT05174169 Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-
Phase 3 · NRG Oncology · NCT06500481 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Merck Sharp & Dohme LLC · NCT06623422 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06876714 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · National Cancer Institute (NCI) · NCT04269902 A Study of Brenipatide in Participants With Opioid Use Disorder
Phase 2 · Eli Lilly and Company · NCT07420283 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Canadian Cancer Trials Group · NCT06592924 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Children's Oncology Group · NCT04293562 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · NRG Oncology · NCT06748222 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Phase 3 · Gershon Pain Specialists, Merz Investigational Site #0010519 · Merz Therapeutics GmbH · NCT07018713 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · NRG Oncology · NCT03180268 Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metas
Phase 2 · National Cancer Institute (NCI) · NCT03606967 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · National Cancer Institute (NCI) · NCT05256225 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Phase 3 · Revolution Medicines, Inc. · NCT06881784 Project: Every Child for Younger Patients With Cancer
Phase N/A · Children's Oncology Group · NCT02402244

Look up another city

Look up another condition